Clinical Trial Update: EGFR CART Cells for Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on phase 1/2 study evaluating EGFR-targeted CAR-T cells for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EGFR CAR-T cells

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: EGFR-positive Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN